Donald Notman is COO at OCULAR THERAPEUTIX, INC (OCUL). They have made 9 open-market trades across 1 company since 2017, most recently 2026-08-31.
CIK 0001718019
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $109K since 2017, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OCUL | 366,529 | $2.5M |
Shares reported on the most recent Form 4, priced at the 2026-09-02 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OCUL | SELL | 2026-08-31 | 2026-09-02 | $10.24 | $11K | -6.9% | -36.7% | — |
| OCUL | SELL | 2026-02-12 | 2026-02-17 | $9.04 | $103K | +26.6% | +17.1% | +18.7% |
| OCUL | SELL | 2026-02-02 | 2026-02-04 | $8.82 | $101K | -21.0% | +16.0% | +9.7% |
| OCUL | SELL | 2025-09-02 | 2025-09-04 | $12.43 | $13K | -2.7% | -14.2% | -10.3% |
| OCUL | SELL | 2025-01-31 | 2025-02-04 | $7.82 | $223K | -6.7% | -5.9% | -0.9% |
| OCUL | SELL · Routine | 2024-02-05 | 2024-02-06 | $4.86 | $30K | +49.5% | +104.5% | +14.4% |
| OCUL | SELL | 2024-01-31 | 2024-02-02 | $4.95 | $32K | +28.2% | +115.9% | +16.5% |
| OCUL | SELL · 10b5-1 | 2023-02-06 | 2023-02-08 | $4.24 | $27K | +40.3% | +19.1% | +60.1% |
| OCUL | BUY | 2019-06-14 | 2019-06-17 | $4.33 | $11K | +3.0% | +11.9% | +1.9% |
| OCUL | BUY | 2018-08-14 | 2018-08-15 | $6.29 | $79K | +5.0% | +0.6% | -14.1% |
| OCUL | BUY | 2017-12-07 | 2017-12-08 | $4.00 | $19K | +6.6% | +14.7% | +38.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.